ArticleThe Lancet regional health. Europe2026
Tuberculosis disease and infection screening among migrants in the Netherlands 2019-2023: a national retrospective observational study.
Article in The Lancet regional health. Europe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Migrants from tuberculosis (TB) high-incidence countries are at increased risk of TB, therefore, screening for TB is frequently implemented in host countries, but evidence for systematic screening for TB infection (TBI) is limited. We evaluated the national migrant TB/TBI screening programme in the Netherlands to assess TB yield, TBI prevalence, and the subsequent cascade of care. Methods: This retrospective observational study included all immigrants and asylum seekers screened for TB and TBI in the Netherlands in 2019-2023. We linked data from the national TB client information system to the Netherlands TB Register to assess TB yield (cases detected per 100,000 screened), TBI prevalence, and treatment initiation and completion, by migrant group, country of birth, and age group. Findings: 149,214 migrants were included (87,511 immigrants; 61,703 asylum seekers). TB at entry was diagnosed in 69 immigrants and 170 asylum seekers, corresponding to yields of 79 per 100,000 (95% CI 62-100) and 276 per 100,000 (237-320), respectively. Among 202 pulmonary TB cases, 129 (63.9%) was bacteriologically confirmed and 147 (72.8%) did not report cough symptoms. TB treatment completion was 92.8% (64/69) among immigrants and 81.2% (138/170) among asylum seekers. TBI screening included 20,378 immigrants. TBI prevalence increased with age, from 0.6% in children <12 years, 4.4% in adolescents 12-17 years, to 12.9% in adults ≥ 18 years. Among them, 64.6% (31/48), 81.5% (66/81), and 64.7% (663/1024), respectively, initiated and completed treatment. Interpretation: Systematic TB and TBI screening among migrants in the Netherlands effectively identifies people with TB, including those without symptoms, and enables TB prevention. These findings support targeted screening policies as a core component of TB prevention and control in low-incidence settings. Funding: This work was supported by the Ministry of Health, Welfare and Sports (VWS), the Netherlands.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.